X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4) 4
female (3) 3
humans (3) 3
male (3) 3
middle aged (3) 3
aged (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
cancer (2) 2
cancer therapies (2) 2
chemotherapy, adjuvant (2) 2
doxorubicin - administration & dosage (2) 2
hematology, oncology and palliative medicine (2) 2
metaanalysis (2) 2
neoadjuvant chemotherapy (2) 2
oncology (2) 2
research (2) 2
abridged index medicus (1) 1
adjuvant chemotherapy (1) 1
adjuvant imatinib (1) 1
adjuvant treatment (1) 1
adolescent (1) 1
adult (1) 1
adults (1) 1
anaemia (1) 1
anesthesia & perioperative care (1) 1
anthracyclines (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
benzamides (1) 1
bladder cancer (1) 1
blood loss (1) 1
canada (1) 1
carcinoma (1) 1
carcinoma - drug therapy (1) 1
carcinoma - mortality (1) 1
carcinoma - pathology (1) 1
carcinoma - surgery (1) 1
care and treatment (1) 1
chemotherapy (1) 1
cisplatin - administration & dosage (1) 1
clinical medicine (1) 1
clinical trials (1) 1
colony-stimulating factor (1) 1
cystectomy - adverse effects (1) 1
cystectomy - mortality (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
disease-free survival (1) 1
double-blind method (1) 1
doxorubicin (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
europe (1) 1
european-organization (1) 1
extremities (1) 1
gastrointestinal neoplasms - drug therapy (1) 1
gastrointestinal neoplasms - mortality (1) 1
gastrointestinal neoplasms - pathology (1) 1
gastrointestinal stromal tumors - drug therapy (1) 1
gastrointestinal stromal tumors - mortality (1) 1
gastrointestinal stromal tumors - secondary (1) 1
gastrointestinal tumors (1) 1
gemcitabine (1) 1
granulocyte colony-stimulating factor - administration & dosage (1) 1
hematology (1) 1
hospitals (1) 1
hypertension (1) 1
ifosfamide - administration & dosage (1) 1
imatinib mesylate (1) 1
indoles - therapeutic use (1) 1
intention to treat analysis (1) 1
internal medicine (1) 1
kaplan-meier estimate (1) 1
kit (1) 1
lymph node excision (1) 1
management (1) 1
mechanisms (1) 1
medical prognosis (1) 1
medical research (1) 1
medicine, general & internal (1) 1
mesylate (1) 1
methotrexate (1) 1
methotrexate - administration & dosage (1) 1
mutation (1) 1
mutations (1) 1
neoplasm staging (1) 1
neoplasms. tumors. oncology. including cancer and carcinogens (1) 1
oncology, experimental (1) 1
patient blood management (1) 1
phenylurea compounds - adverse effects (1) 1
phenylurea compounds - therapeutic use (1) 1
piperazines - therapeutic use (1) 1
plus cisplatin (1) 1
plus ifosfamide (1) 1
practice change (1) 1
proportional hazards models (1) 1
protein kinase inhibitors - adverse effects (1) 1
protein kinase inhibitors - therapeutic use (1) 1
proteins (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1045 - 1054
Journal Article
Best Practice & Research: Clinical Anaesthesiology, ISSN 1521-6896, 2012, Volume 27, Issue 1, pp. 43 - 58
Patient blood management is now high on national and international health-system agendas. Serious supply challenges as a result of changing population... 
Anesthesia & Perioperative Care | practice change | transfusion | anaemia | patient blood management | blood loss
Journal Article
Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 76 - 86
Summary Background Patients with muscle-invasive urothelial carcinoma of the bladder have poor survival after cystectomy. The EORTC 30994 trial aimed to... 
Hematology, Oncology and Palliative Medicine | ADJUVANT CHEMOTHERAPY | PLUS CISPLATIN | METAANALYSIS | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | DOXORUBICIN | METHOTREXATE | VINBLASTINE | CANCER | GEMCITABINE | Lymph Node Excision | Cystectomy - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Male | Vinblastine - administration & dosage | Cystectomy - adverse effects | Urothelium - pathology | Cisplatin - administration & dosage | Time Factors | Urinary Bladder Neoplasms - pathology | Female | Chemotherapy, Adjuvant | Carcinoma - pathology | Doxorubicin - administration & dosage | Carcinoma - drug therapy | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Time-to-Treatment | Carcinoma - surgery | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Methotrexate - administration & dosage | Urothelium - surgery | Neoplasm Staging | Urothelium - drug effects | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Carcinoma | Hospitals | Cancer
Journal Article
Sarcoma, ISSN 1357-714X, 09/2002, Volume 6, Issue 3, pp. 83 - 87
Gastrointestinal stromal tumour (GIST) is the commonest mesenchymal tumour to affect the gastrointestinal tract. Appropriate management requires accurate... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.